A Study of the Safety of REN001 in Patients With McArdle Disease
Clinical trial NCT04226274 · COMPLETED
Trial details
- NCT number
- NCT04226274
- Sponsor
- Reneo Pharma Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-10
- Primary completion
- 2021-10-11
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.